Literature DB >> 21536351

[Accesibility and tolerability on the use of subcutaneous hormone implants in a socially excluded population].

Vanessa Domínguez Úbeda1, Patricia Avila Pecci, María Josefa Espinaco Garrido, José Román Oliver.   

Abstract

OBJECTIVE: To determine the acceptability and tolerability of subcutaneous implants used in a socially excluded population from El Vacie, Seville.
DESIGN: Prospective cohort study with follow-up.
SETTING: Pino Montano B Outpatient Department in Seville, Spain. PARTICIPANTS: A total of 66 females between 15-49 years who had a subcutaneous implant inserted, of whom 44.6% were from El Vacie (a shantytown outside Seville, Spain).
INTERVENTIONS: Pre-implant questionnaire, placing of the implant and a post-implant questionnaire 3 months later. MAIN MEASUREMENTS: A study of the sociodemographic variables with frequency tables. Comparison of the tolerability with the place of residence variable (from El Vacie/not from El Vacie) using the Chi squared statistic, and the acceptability with frequency tables.
RESULTS: There were no statistically significant differences between the tolerability variables studied (P=.618), with a (relative risk) RR of 1.33 (0.430-4.134). The women not from El Vacie were less tolerant than the women from El Vacie. The great majority of women (93.1% El Vacie women and 88.9% non-El Vacie women) would come back to use this contraceptive method again after it expires in 3 years, and 84.7% of El Vacie women and 82.4% of those not from El Vacie considered the method as excellent.
CONCLUSIONS: Subcutaneous hormone implants were a safe, tolerable and accepted method with no cultural differences.
Copyright © 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536351      PMCID: PMC7025154          DOI: 10.1016/j.aprim.2010.11.010

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  4 in total

1.  An integrated analysis of nonmenstrual adverse events with Implanon.

Authors:  J Urbancsek
Journal:  Contraception       Date:  1998-12       Impact factor: 3.375

2.  Self-described impact of noncompliance among users of a combined hormonal contraceptive method.

Authors:  Iñaki Lete; José Luis Doval; Ezequiel Pérez-Campos; Roberto Lertxundi; Marta Correa; Esther de la Viuda; María Angeles Gómez; José Vicente González; María Teresa Martínez; Nicolás Mendoza; Javier Robledo
Journal:  Contraception       Date:  2008-01-22       Impact factor: 3.375

3.  The cost-effectiveness of a long-acting reversible contraceptive (Implanon) relative to oral contraception in a community setting.

Authors:  Clare Lipetz; Ceri J Phillips; Charlotte F Fleming
Journal:  Contraception       Date:  2008-12-11       Impact factor: 3.375

4.  A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.

Authors:  A Sheth; U Jain; S Sharma; A Adatia; S Patankar; L Andolsek; A Pretnar-Darovec; M A Belsey; P E Hall; R A Parker; S Ayeni; A Pinol; C Li Hoi Foo
Journal:  Contraception       Date:  1982-03       Impact factor: 3.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.